Aptevo Therapeutics Inc. Warrant Agreements
36 Contracts & Agreements
- Form of Amended Warrant, dated September 18, 2024 (originally entered into on July 1, 2024), between the Company and certain warrant holders (Filed With SEC on September 18, 2024)
- Form of Amended Warrant, dated September 18, 2024 (originally entered into on April 15, 2024), between the Company and certain warrant holders (Filed With SEC on September 18, 2024)
- Form of Amended Series B-2 Common Warrant, dated September 18, 2024 (originally entered into on November 9, 2023), between the Company and certain warrant holders (Filed With SEC on September 18, 2024)
- Form of Amended Series B-1 Common Warrant, dated September 18, 2024 (originally entered into on November 9, 2023), between the Company and certain warrant holders (Filed With SEC on September 18, 2024)
- Form of Amended Series A-2 Common Warrant, dated September 18, 2024 (originally entered into on November 9, 2023), between the Company and certain warrant holders (Filed With SEC on September 18, 2024)
- Form of Amended Series A-1 Common Warrant, dated September 18, 2024 (originally entered into on November 9, 2023), between the Company and certain warrant holders (Filed With SEC on September 18, 2024)
- Pre-funded Warrant, dated September 18, 2024 (Filed With SEC on September 18, 2024)
- Common Warrant, dated September 18, 2024 (Filed With SEC on September 18, 2024)
- Form of Common Warrant (Filed With SEC on August 30, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on August 30, 2024)
- Form of Amended Series B-2 Common Warrant, dated as of July 1, 2024, between the Company and certain warrant holders (Filed With SEC on July 1, 2024)
- Form of Amended Series B-1 Common Warrant, dated as of July 1, 2024, between the Company and certain warrant holders (Filed With SEC on July 1, 2024)
- Form of Amended Series A-2 Common Warrant, dated as of July 1, 2024, between the Company and certain warrant holders (Filed With SEC on July 1, 2024)
- Form of Amended Series A-1 Common Warrant, dated as of July 1, 2024, between the Company and certain warrant holders (Filed With SEC on July 1, 2024)
- Form of Amended Series A Common Warrant, dated as of July 1, 2024, between the Company and certain warrant holders (Filed With SEC on July 1, 2024)
- Form of Amended Common Warrant, dated as of July 1, 2024, between the Company and certain warrant holders (Filed With SEC on July 1, 2024)
- Pre-Funded Warrant, dated July 1, 2024 (Filed With SEC on July 1, 2024)
- Common Warrant, dated July 1, 2024 (Filed With SEC on July 1, 2024)
- Form of Common Warrant (Filed With SEC on June 14, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on June 14, 2024)
- Pre-funded Warrant, dated April 15, 2024 (Filed With SEC on April 15, 2024)
- Common Warrant, dated April 15, 2024 (Filed With SEC on April 15, 2024)
- Form of Common Warrant (Filed With SEC on March 20, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on March 20, 2024)
- Form of Warrant Inducement Agreement, by and between the Company and each Holder (Filed With SEC on November 9, 2023)
- Form of New Series B-2 Warrant (Filed With SEC on November 9, 2023)
- Form of New Series B-1 Warrant (Filed With SEC on November 9, 2023)
- Form of New Series A-2 Warrant (Filed With SEC on November 9, 2023)
- Form of New Series A-1 Warrant (Filed With SEC on November 9, 2023)
- Pre-funded Warrant, dated August 4, 2023 (Filed With SEC on August 7, 2023)
- Series B Common Warrant, dated August 4, 2023 (Filed With SEC on August 7, 2023)
- Series A Common Warrant, dated August 4, 2023 (Filed With SEC on August 7, 2023)
- Form of Common Warrant (Filed With SEC on July 14, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on July 14, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on March 11, 2019)
- Form of Warrant (Filed With SEC on March 11, 2019)
